← Back to headlines
BioNTech SE Rallies on Strong Oncology Strategy
BioNTech SE (BNTX) is experiencing a rally in its stock due to a solid oncology strategy.
19 Feb, 08:43 — 19 Feb, 08:43
Sources
Showing 1 of 1 sources
BioNTech SE (BNTX) is experiencing a rally in its stock due to a solid oncology strategy.
